Nicotine - Retracted Studies, Papers, and Articles: Difference between revisions

 
Line 266: Line 266:
===2024: Comments RE: [https://www.ecigarette-research.org/research/index.php/research/2024/281-ecig-disease Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes]===
===2024: Comments RE: [https://www.ecigarette-research.org/research/index.php/research/2024/281-ecig-disease Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes]===
*"The study provides zero evidence on any risk associated with e-cigarette use, whether absolute risk or in comparison with smoking. The question that was supposed to be addressed in this metanalysis CANNOT be examined with the studies included in their analysis." (Farsalinos)
*"The study provides zero evidence on any risk associated with e-cigarette use, whether absolute risk or in comparison with smoking. The question that was supposed to be addressed in this metanalysis CANNOT be examined with the studies included in their analysis." (Farsalinos)
*[https://pubpeer.com/publications/9E38A75C420D1F19DA0D48C37FA8D8 See Also]: "The methods look impressive, but the devil is in the dirty details buried in the nearly 100 pages supplemental material. The authors have done an admirable job collecting studies and organizing them, but the conclusions reached are untenable, and unsupportable at least for now." (Cummings)
*Referring to: Glantz SA, Nguyen N, Oliveira da Silva AL. Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes. NEJM Evid. 2024 Mar;3(3):EVIDoa2300229. Epub 2024 Feb 27. PMID: 38411454. [https://evidence.nejm.org/doi/full/10.1056/EVIDoa2300229 doi: 10.1056/EVIDoa2300229]
*Referring to: Glantz SA, Nguyen N, Oliveira da Silva AL. Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes. NEJM Evid. 2024 Mar;3(3):EVIDoa2300229. Epub 2024 Feb 27. PMID: 38411454. [https://evidence.nejm.org/doi/full/10.1056/EVIDoa2300229 doi: 10.1056/EVIDoa2300229]